Quotes 5-day view Delayed Nasdaq
08/09/2022
08/10/2022
08/11/2022
08/12/2022
08/15/2022
Date
105.24(c)
107.33(c)
109.18(c)
109.84(c)
112.23(c)
Last
444 024
402 451
578 529
174 676
264 431
Volume
-3.86% +1.99% +1.72% +0.60% +2.18% Change
Estimated financial data (e) (USD)
Sales 2022
1 396 M - -
Net income 2022
56,9 M - -
Net Debt 2022
120 M - -
P/E ratio 2022
84,1x
Yield 2022
-
Sales 2023
1 569 M - -
Net income 2023
96,7 M - -
Net Debt 2023
56,2 M - -
P/E ratio 2023
50,7x
Yield 2023
-
Capitalization
4 971 M 4 971 M -
EV / Sales 2022
3,65x
EV / Sales 2023
3,20x
Nbr of Employees
4 000
Free-Float
80,0%
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced services offerings. The Company's point-of-care automation solutions are designed to improve...
Ratings of Omnicell, Inc.
All news about OMNICELL, INC.
08/09 OMNICELL, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS.. AQ
08/08 Piper Sandler Adjusts Omnicell's Price Target to $150 From $162, Reiterates Overweight .. MT
08/05 Berenberg Bank Adjusts Omnicell's Price Target to $152 From $162, Maintains Buy Rating MT
08/04 OMNICELL : Q2 Earnings SnapshotAQ
08/04 TRANSCRIPT : Omnicell, Inc., Q2 2022 Earnings Call, Aug 04, 2022CI
08/04 OMNICELL : Announces Financial Results for Second Quarter 2022 - Form 8-KPU
08/04 OMNICELL, INC. : Results of Operations and Financial Condition, Other Events, Financial St..AQ
08/04 Earnings Flash (OMCL) OMNICELL Posts Q2 EPS $0.84 MT
08/04 Omnicell Announces Financial Results for Second Quarter 2022 BU
08/04 Earnings Flash (OMCL) OMNICELL Reports Q2 Revenue $332M MT
08/04 Omnicell, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended Jun.. CI
08/04 Omnicell, Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2022 CI
07/27 BTIG Adjusts Omnicell's Price Target to $175 from $190, Keeps Buy Rating MT
07/15 SVB Securities Initiates Coverage on Omnicell With Market Perform Rating, $124 Price Ta.. MT
07/11 Omnicell to Release Second Quarter 2022 Financial Results on August 4, 2022 BU
News in other languages on OMNICELL, INC.
Analyst Recommendations on OMNICELL, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends OMNICELL, INC.
Short Term Mid-Term Long Term Trends Neutral Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
8
Last Close Price
112,23 $
Average target price
155,88 $
Spread / Average Target
38,9%
Please enable JavaScript in your browser's settings to use dynamic charts.
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
